Simultaneous plasma and genital pharmacokinetics and pharmacodynamics of atazanavir and efavirenz in HIV-infected women starting therapy.

about

Simultaneous plasma and genital pharmacokinetics and pharmacodynamics of atazanavir and efavirenz in HIV-infected women starting therapy.

Item

http://www.wikidata.org/entity/Q35706140

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Simultaneous plasma and genita ...... fected women starting therapy.

@ast

Simultaneous plasma and genita ...... fected women starting therapy.

@en

type

Item

label

Simultaneous plasma and genita ...... fected women starting therapy.

@ast

Simultaneous plasma and genita ...... fected women starting therapy.

@en

prefLabel

Simultaneous plasma and genita ...... fected women starting therapy.

@ast

Simultaneous plasma and genita ...... fected women starting therapy.

@en

P1476

Simultaneous plasma and genita ...... fected women starting therapy.

@en

P2093

Andrea Kovacs

http://www.w3.org/2001/XMLSchema#string

Jiaao Xu

http://www.w3.org/2001/XMLSchema#string

Kasalyn Thuvamontolrat

http://www.w3.org/2001/XMLSchema#string

Michael Neely

http://www.w3.org/2001/XMLSchema#string

Nicholas Mordwinkin

http://www.w3.org/2001/XMLSchema#string

Patricia Anthony

http://www.w3.org/2001/XMLSchema#string

Stan Louie

http://www.w3.org/2001/XMLSchema#string

P2860

Prevention of HIV-1 infection with early antiretroviral therapy

Antiretroviral pharmacology in mucosal tissues

Decay characteristics of HIV-1-infected compartments during combination therapy

Correlates of HIV-1 genital shedding in Tanzanian women.

Comparison of two amplification technologies for detection and quantitation of human immunodeficiency virus type 1 RNA in the female genital tract. Division of AIDS Treatment Research Initiative 009 Study Team.

HIV-1 genital shedding is suppressed in the setting of high genital antiretroviral drug concentrations throughout the menstrual cycle.

Cervical shedding of HIV-1 RNA among women with low levels of viremia while receiving highly active antiretroviral therapy

Permissive and protective factors associated with presence, level, and longitudinal pattern of cervicovaginal HIV shedding

Accurate detection of outliers and subpopulations with Pmetrics, a nonparametric and parametric pharmacometric modeling and simulation package for R

Genital tract viral load in HIV Type 1-positive women correlates with specific cytokine levels in cervical-vaginal secretions but is not a determinant of infectious virus or anti-HIV activity.

P304

798-808

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCPH.481

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25683232

http://www.w3.org/2001/XMLSchema#string

P932

4461473

http://www.w3.org/2001/XMLSchema#string